VAXIMM

Vaximm is a company that creates vaccines for cancer patients. Their first product, VXM01, targets the tumor vasculature to prevent tumors from growing. Vaximm has had success in animal studies and will begin testing on humans in 2011. They are also developing oral T-cell immunotherapies....